Drug Trial Radar · NCT06881836
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
260
Actual
Start
Apr 24, 2025
Primary completion
Jul 31, 2026
Study completion Sep 1, 2026
Sponsor
- Lead sponsor
- Ono Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether administering ONO-2020, an epigenetic regulator, may improve cognitive functions like memory and cognition in individuals with Alzheimer's disease dementia.
Conditions
- Alzheimer Disease
Interventions
ONO-2020Drug
ONO-2020 group: Two ONO-2020 tablets will be orally administered once daily.
PlaceboDrug
Placebo group: Two ONO-2020 placebo tablets will be orally administered once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity, and type of treatment emergent adverse events (TEAEs)Time frame: From baseline up to 26 weeks
- Clinically abnormal findings in Columbia Suicide Severity Rating Scale (C-SSRS)Time frame: From baseline up to 26 weeks
- Change from baseline through week 26 in Alzheimer's Disease Assessment Scale-Cognitive Subscale 12 (ADAS-cog 12) scoreTime frame: From baseline up to 26 weeks
Locations
80 sites in 2 countries. Site status is shown where the registry gives one.
Banner Alzheimer's Institute (BAI)
Phoenix, Arizona
Clinical Endpoints
Scottsdale, Arizona
Banner Sun Health Research Institute
Sun City, Arizona
Center for Neurosciences-Research
Tucson, Arizona
Profound Research LLC at The Neurology Center of Southern California
Carlsbad, California
Neurology Center of North Orange County
Fullerton, California
Stanford University
Palo Alto, California
Sunwise Clinical Research
Walnut Creek, California
CenExel Rocky Mountain Clinical Research
Englewood, Colorado
Brain Matters Research
Delray Beach, Florida
Quantum Clinical Trials
Miami Beach, Florida
Suncoast Clinical Research
New Port Richey, Florida
Renstar Medical Research
Ocala, Florida
Charter Research - Orlando
Orlando, Florida
Accel Research Sites - Brain and Spine Institute
Port Orange, Florida
USF Health Byrd Alzheimer's Institute
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
Charter Research - The Villages
The Villages, Florida
Conquest Research LLC
Winter Park, Florida
Sandhill Research, LLC d/b/a Accel Research Sites - NeuroStudies CRU
Decatur, Georgia
CenExel iResearch, LLC
Savannah, Georgia
Velocity Clinical Research, Boise
Meridian, Idaho
Re:Cognition Health-Chicago
Chicago, Illinois
Ascension Alexian Brothers Medical Center
Elk Grove Village, Illinois
University of Kansas Medical Center
Fairway, Kansas
Univ of Kentucky Sanders-Brown Center on Aging
Lexington, Kentucky
Boston Clinical Trials
Boston, Massachusetts
ActivMed Research
Methuen, Massachusetts
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada
Vector Clinical Trials
Las Vegas, Nevada
The Cognitive and Research Center of New Jersey
Springfield, New Jersey
Advanced Memory Research Institute of NJ (CenExel AMRI)
Toms River, New Jersey
Advanced Clinical Institute Inc.
West Long Branch, New Jersey
University at Buffalo
Buffalo, New York
The Feinstein Institutes for Medical Research
Manhasset, New York
NYU Center for Cognitive Neurology
New York, New York
AD-CARE; University of Rochester
Rochester, New York
Stony Brook University Hospital
Stony Brook, New York
New Hope Clinical Research
Charlotte, North Carolina
Velocity Clinical Research at Raleigh Neurology
Raleigh, North Carolina
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.